Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 06, 2024 12:59pm
RE:RE:RE:ANDA/NDA
Ummm, nobody is disputing that a ANDA was submitted. What is clear is that it is not for breast cancer or opiate withdrawal.
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 06, 2024 12:12pm
RE:RE:ANDA/NDA
So yes it is HAPPENING...medipharm labs has a customer who's submitted a NEW DRUG APPLICATION...last year...a Corp submits such application once trials are complete..all necessary steps have been
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 06, 2024 12:07pm
RE:ANDA/NDA
Please refer to the investors deck on the corporate website..."customers in all phases of drug development ANDA...NDA...505b2...
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Post by
QContinuum1
on Mar 06, 2024 11:38am
ANDA/NDA
Given that there are no completed PHIII trials on any of the uses being tossed around....there is no chance FDA approval will be granted on any of them. LABS already came out and said what the ANDA
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 06, 2024 8:11am
NDA....I'm thinking breast cancer...one of the most
common forms of cancers. That has already been scientifically proven effective in published research papers that select combination of cannabinoid compounds induce apoptosis in breast
...more
(100)
•••
Solid1
X
View Profile
View Bullboard History
Post by
Solid1
on Mar 06, 2024 3:51am
ANDA/NDA
Opiate withdrawal will be the medication. That's what my guts is telling me. I couldn't find a patent that covers that either, and I think that's what's most needed in the US. There
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 05, 2024 8:57pm
RE:Melanoma Cancer
That is correct, the cannabinoid compounds disrupts the cancer cell's ability to replicate leading to it's self destruction and....Australia has one of the highest rates of skin cancer as well
...more
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Comment by
Olaf123
on Mar 05, 2024 8:17pm
RE:RE:RE:Melanoma Cancer
The human skin has the endocannabinoid system composed of enzymes, receptors, and ligands which regulates skin homeostasis including the release of inflammatory compounds, cell differentiation, and
...more
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Comment by
Olaf123
on Mar 05, 2024 7:50pm
RE:RE:Melanoma Cancer
https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&p=PMC3&id=10605078_cells-12-02450-g002.jpg
(29)
•••
Olaf123
X
View Profile
View Bullboard History
Comment by
Olaf123
on Mar 05, 2024 7:48pm
RE:Melanoma Cancer
PHEC-66 is 60% CBD.
(758)
•••
Danno13
X
View Profile
View Bullboard History
Post by
Danno13
on Mar 05, 2024 6:47pm
Melanoma Cancer
Scientists in Australia have discovered that a specific extract from cannabis can kill skin cancer cells. This anti-cancer effect can force melanoma cells into a “programmed cell death
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Post by
subaru1
on Mar 05, 2024 1:35pm
Fda approved
The agency has, however, approved one cannabis-derived drug product: Epidiolex (cannabidiol), and three synthetic cannabis-related drug products: Marinol (dronabinol), Syndros (dronabinol
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 05, 2024 10:35am
Hey Steve, a new Blaser F3 Luxe trap model for you?
And I don't buy it for a second that you're not looking to upgrade...I saw you drooling over Dr. Hammer's Blaser F3. PULL!!!!!!!!!!!! (Ed) Waaaa
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 05, 2024 10:28am
How do we know LABS, Pfizer, and we are waiting on DEA?
I posted the answer yesterday from the Q4, 2022 press release. Let me refresh everyone's memory per below again. in 2022 MediPharm contributed active pharmaceutical ingredients to an
...more
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >